Full-Time

Associate Director or Director

Supply Chain

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops targeted protein degradation therapies

Biotechnology
Healthcare

Expert

Belmont, MA, USA

Category
Supply Chain Management
Operations & Logistics
Required Skills
Inventory Management
Requirements
  • BA/BS in Supply Chain/Operations or life sciences/health-related field.
  • 10+ years of experience in clinical supply chain management in the pharmaceutical industry
  • Experience with managing contract organizations for clinical labeling, packaging and distribution
  • Experience with clinical blinding practices and implementation of IRT systems
  • Knowledge of global and regional regulations pertaining to labeling and packaging, cGMP requirements and good distribution practices
  • Working knowledge of import and export requirements, including proficiency in document preparation and international shipping logistics
  • Expertise to support, as needed, the investigation and resolution of complaints, product rejections, non-conformances, recalls, deviations, and trends from process performance
  • Able to work in a fast-paced environment while handling multiple priorities
Responsibilities
  • Packaging, labeling, and distribution of clinical supplies from study initiation through closeout
  • Develop a clinical supply chain strategy, budget and forecast in coordination with CMC and Clinical functions
  • Coordinate and manage distribution of clinical trial material to depots and sites for clinical studies
  • Manage clinical packaging/distribution vendors, including negotiating contracts, reviewing batch documentation, designing and developing the distribution strategy
  • Participate in the setup, testing and operation of interactive supply tracking systems (IRT)
  • Represent the Supply Chain function on CMC and Clinical Study Teams and serve as the interface between the CMC and clinical teams to ensure smooth conduct of clinical studies
  • Coordinate import and export of materials to support clinical and non-clinical studies
  • Materials management for GLP toxicology and clinical materials, including maintenance of inventory database and documentation related to material receipt, storage and distribution
  • Ensure compliance with industry standards, Good Manufacturing Practices (GMP) and applicable state and federal regulatory requirements
Desired Qualifications
  • Skills and experience not an exact match are welcomed, and candidates are encouraged to submit their resume for future opportunities.

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that address unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera raised $225M and $275M in public offerings, boosting financial resources.
  • HSBC's investment indicates strong confidence in Kymera's business model and prospects.
  • Partnership with Neosphere Biotechnologies opens new therapeutic opportunities in molecular glue discovery.

What critics are saying

  • Increased competition in protein degradation could impact Kymera's market share.
  • Regulatory scrutiny may delay clinical trials and drug approval timelines.
  • Dependence on key partnerships like Sanofi could affect revenue if altered.

What makes Kymera Therapeutics unique

  • Kymera's Pegasus Platform enables precise identification and degradation of disease-causing proteins.
  • The company focuses on targeted protein degradation, a novel approach in drug development.
  • Kymera's strategic partnership with Sanofi enhances its credibility and market reach.

Help us improve and share your feedback! Did you find this helpful?